Gabapentin Dementia Lawsuit in Alabama - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Alabama ranks among the highest gabapentin-prescribing states in the nation, with per-capita prescription rates nearly double the national average — a pattern driven by elevated chronic pain prevalence, limited specialist access in rural counties, and the state's severe opioid crisis that pushed physicians toward gabapentinoids as alternatives. Alabama classified gabapentin as a Schedule V controlled substance in 2019, acknowledging the misuse and dependence potential that manufacturers had long minimized. The state's prescription drug monitoring program data reveals gabapentin is frequently co-prescribed with opioids in Alabama, a combination the FDA warned in 2019 can cause respiratory depression and death. Jefferson County (Birmingham) and Mobile County courts have active pharmaceutical litigation dockets, and Alabama's plaintiff-friendly venue rules make it a strong jurisdiction for gabapentin cognitive decline claims.

Written By

People's Justice Legal Research Team

Statute of Limitations

Alabama: 2 years for product liability (Ala. Code § 6-2-38(l)). Discovery rule applies — the limitations period begins when the plaintiff discovers or reasonably should have discovered the injury and its connection to gabapentin. Alabama also has a 10-year statute of repose for product liability claims (Ala. Code § 6-5-502).

2 years from discovery of injury

Filing Venue

Where to File in Alabama

Gabapentin dementia cases in Alabama may be filed in federal court in the Northern District (Birmingham), Middle District (Montgomery), or Southern District (Mobile). Jefferson County Circuit Court in Birmingham is a historically plaintiff-favorable venue for pharmaceutical litigation. Alabama classified gabapentin as a Schedule V controlled substance, and PDMP data can support claims about prescribing patterns. Alabama applies the Alabama Extended Manufacturer's Liability Doctrine (AEMLD) for product liability claims.

Alabama Data

Exposure in Alabama

Source: IQVIA / CDC prescribing data

Source: Alabama Board of Pharmacy

Source: CDC Opioid Prescribing Data / AL PDMP

FAQ

Frequently Asked Questions

See details below.

Back to Gabapentin Dementia Lawsuit Lawsuit Overview